A randomised double blind controlled study of the effects of methylphenidate on Central Audition Deficits

ISRCTN ISRCTN35253389
DOI https://doi.org/10.1186/ISRCTN35253389
Secondary identifying numbers N/A
Submission date
06/11/2002
Registration date
06/11/2002
Last edited
13/08/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Laurence Jerome
Scientific

90 Wharncliffe Rd South
London, Ontario
N6J 2K1
Canada

Phone +1 519 432 3818
Email ljerome@rogers.com

Study information

Study designRandomised placebo controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study acronymCAD
Study objectivesNot provided at time of registration.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCentral Audition Deficit (Central Auditory Processing Disorder [CAPD])
InterventionRetesting the central audition on methylphenidate or placebo
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Methylphenidate (Ritalin®)
Primary outcome measureNot provided at time of registration.
Secondary outcome measuresNot provided at time of registration.
Overall study start date01/04/2002
Completion date30/04/2003

Eligibility

Participant type(s)Patient
Age groupChild
SexBoth
Target number of participants62
Key inclusion criteriaSixty-two consecutive attendees at a university clinic for communication disorders referred for evaluation of learning and listening problems at school by parents, teachers or family physicians and shown to have deficits of Central Audition on a Willeford standardised test battery
Key exclusion criteriaDoes not match inclusion criteria
Date of first enrolment01/04/2002
Date of final enrolment30/04/2003

Locations

Countries of recruitment

  • Canada

Study participating centre

90 Wharncliffe Rd South
London, Ontario
N6J 2K1
Canada

Sponsor information

University of Western Ontario (Canada)
University/education

1151 Richmond Street, Suite 2
London, Ontario
N6A 4B8
Canada

Phone +1 519 661 2111
Email wnonline@uwo.ca
Website http://www.med.uwo.ca/
ROR logo "ROR" https://ror.org/02grkyz14

Funders

Funder type

Other

Self funded

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan